Please login to the form below

Not currently logged in
Email:
Password:

Forty Seven

This page shows the latest Forty Seven news and features for those working in and with pharma, biotech and healthcare.

Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops

Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops

Gilead also noted net loss for the second quarter could be also be attributed to charges related to its recent acquisition of immuno-oncology biotech Forty Seven.

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics